E. Jaeger

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens

E. Jaeger, Helga Bernhard, Pedro Romero et al. · International Journal of Cancer · 1996 · 244 citations

Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.

Salah‐Eddin Al‐Batran, Nils Homann, Harald Schmalenberg et al. · Journal of Clinical Oncology · 2017 · 238 citations

Surgical Oncology, Esophageal Cancer, Cancer Management +16

A randomized, double-blind, placebo-controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222584 or placebo (CONFIRM-1)

J. Randolph Hecht, Tanja Trarbach, E. Jaeger et al. · Journal of Clinical Oncology · 2005 · 201 citations

Tyrosine Kinase, Pathology, Surgery +17

Phase II Trial of Biweekly Infusional Fluorouracil, Folinic Acid, and Oxaliplatin in Patients With Advanced Gastric Cancer

Salah‐Eddin Al‐Batran, Akin Atmaca, Susanna Hegewisch‐Becker et al. · Journal of Clinical Oncology · 2004 · 184 citations · Full text

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Elena Neumann, Arne Engelsberg, Jean Decker et al. · PubMed · 1998 · 167 citations

T-regulatory Cell, Immunology, Tumor-associated Antigens Rage-1 +19